Pharmacokinetics study of Pioglitazone (30 mg) tablets in healthy volunteers

  • Sajal K Saha Department of Clinical Pharmacy & Pharmacology, University of Dhaka, Dhaka-1000
  • AK Azad Chowdhury Department of Clinical Pharmacy & Pharmacology, University of Dhaka, Dhaka-1000
  • Sitesh C Bachar Department of Pharmaceutical Technology, University of Dhaka, Dhaka-1000
Keywords: Pioglitazone hydrochloride, tablet, pharmacokinetics, HPLC

Abstract

Pioglitazone, an excellent insulin sensitizer, is used for the treatment of type 2 diabetes mellitus (T2DM). The present investigation demonstrated a single dose pharmacokinetic study of pioglitazone tablet in 24 healthy male volunteers in a randomized protocol. Blood samples were collected before and 0.5 to 24.0 h after a single oral dose of a 30 mg pioglitazone tablet. Plasma pioglitazone level was determined using a validated method of reversed phase binary high performance liquid chromatography (HPLC). The pharmacokinetic parameters determined were 1.117 ± 0.315 (?g/ml), 2.5 ± 0.735 (h), 9.014 ± 3.385 (?g.h/ml), 8.081 ± 3.407 (?g. h/ml), 1.315 ± 0.964 (h), 0.707 ± 1.636 (h-1), 0.078 ± 0.02 (h-1) and 8.884 ± 03.808 (h) for Cmax, Tmax, AUC0-?, AUC0-24, Ka, T1/2 (?), Kel, and T1/2(?), respectively. Variation of pioglitazone pharmacokinetic parameters in Bangladeshi population compared to Chinese, Thai and German population may indicate the polymorphic variation in the pioglitazone responsive metabolizing gene CYP3A4 and CYP2C19 in our population.

DOI: http://dx.doi.org/10.3329/dujps.v13i2.21896

Dhaka Univ. J. Pharm. Sci. 13(2): 181-186, 2014 (December)

Downloads

Download data is not yet available.
Abstract
1001
PDF
886
Published
2015-02-05
How to Cite
Saha, S., Chowdhury, A., & Bachar, S. (2015). Pharmacokinetics study of Pioglitazone (30 mg) tablets in healthy volunteers. Dhaka University Journal of Pharmaceutical Sciences, 13(2), 181-186. https://doi.org/10.3329/dujps.v13i2.21896
Section
Articles